JESSICA PHILLIPS: Open Payments
NPI 1528735875 · FENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 113 payments from 34 companies in 2025. Trend: 2023 $2,539 · 2024 $2,278 · 2025 $2,098
Food & beverage: $2,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $285 |
| AstraZeneca Pharmaceuticals LP | 9 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $137 |
| Novo Nordisk Inc | 10 | $135 |
| Lilly USA, LLC | 4 | $108 |
| Aimmune Therapeutics, Inc. | 4 | $103 |
| PFIZER INC. | 5 | $94 |
| SANOFI-AVENTIS U.S. LLC | 3 | $91 |
| Exact Sciences Corporation | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $83 |
Products named: CAPLYTA, VRAYLAR, MOUNJARO, REXULTI, TZIELD, ZENPEP, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across MO — which companies pay providers there.
